U.K. stocks were little changed, capping their biggest weekly advance since October.
Drugmakers AstraZeneca Plc and GlaxoSmithKline Plc added at least 1 percent, among the biggest positive contributors to the FTSE 100 Index. Barclays Plc slid 3.5 percent after Morgan Stanley cut its recommendation on the stock and said tougher regulation may hurt dividends and growth at British lenders. Lloyds Banking Group Plc and Royal Bank of Scotland Group Plc also fell.
The FTSE 100 Index added less than 0.1 percent at the close in London, paring an advance of as much as 0.5 percent. The benchmark gauge gained 3.5 percent this week after Federal Reserve policy makers signaled faith in the world’s biggest economy and stressed that the pace of rate increases will be gradual.
The broader FTSE All-Share Index gained 0.1 percent and Ireland’s ISEQ Index climbed 0.3 percent today.